Patrick Donnelly
Stock Analyst at Citigroup
(5.00)
# 8
Out of 4,810 analysts
326
Total ratings
49.43%
Success rate
147.71%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Maintains: Neutral | $90 → $85 | $74.59 | +13.96% | 16 | Apr 7, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $290 → $215 | $145.29 | +47.98% | 9 | Apr 7, 2025 | |
| BRKR Bruker | Maintains: Buy | $75 → $50 | $38.43 | +30.11% | 15 | Apr 7, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,400 | $1,046.58 | +33.77% | 13 | Apr 7, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $20 → $15 | $8.16 | +83.82% | 12 | Mar 4, 2025 | |
| AVTR Avantor | Maintains: Neutral | $22 → $18 | $15.40 | +16.88% | 8 | Mar 4, 2025 | |
| TECH Bio-Techne | Maintains: Neutral | $80 → $70 | $51.07 | +37.07% | 11 | Mar 4, 2025 | |
| HOLX Hologic | Maintains: Neutral | $80 → $70 | $57.86 | +20.98% | 14 | Mar 4, 2025 | |
| IQV IQVIA Holdings | Maintains: Neutral | $225 → $210 | $149.15 | +40.80% | 10 | Mar 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Neutral | $650 → $570 | $441.00 | +29.25% | 19 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $167.23 | +10.63% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $155 → $175 | $105.85 | +65.33% | 20 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $189.92 | +39.53% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $4.86 | +373.25% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $44 → $50 | $26.56 | +88.25% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $10.50 | +90.48% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $43.67 | +71.74% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $450 | $244.98 | +83.69% | 14 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $450 | $225.29 | +99.74% | 14 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $103.12 | +60.01% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $44.85 | +0.33% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $22.64 | +23.67% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $95.54 | +51.77% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $41.53 | +48.81% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $323.44 | -7.25% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.93 | +207.17% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $3.30 | -16.67% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $226.02 | +15.03% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $3.26 | +84.05% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $8.01 | +299.50% | 2 | Nov 30, 2018 |
Illumina
Apr 7, 2025
Maintains: Neutral
Price Target: $90 → $85
Current: $74.59
Upside: +13.96%
ICON Public Limited Company
Apr 7, 2025
Maintains: Buy
Price Target: $290 → $215
Current: $145.29
Upside: +47.98%
Bruker
Apr 7, 2025
Maintains: Buy
Price Target: $75 → $50
Current: $38.43
Upside: +30.11%
Mettler-Toledo International
Apr 7, 2025
Upgrades: Buy
Price Target: $1,400
Current: $1,046.58
Upside: +33.77%
10x Genomics
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $8.16
Upside: +83.82%
Avantor
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $15.40
Upside: +16.88%
Bio-Techne
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $51.07
Upside: +37.07%
Hologic
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $57.86
Upside: +20.98%
IQVIA Holdings
Mar 4, 2025
Maintains: Neutral
Price Target: $225 → $210
Current: $149.15
Upside: +40.80%
Thermo Fisher Scientific
Mar 4, 2025
Maintains: Neutral
Price Target: $650 → $570
Current: $441.00
Upside: +29.25%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $167.23
Upside: +10.63%
Mar 4, 2025
Upgrades: Neutral
Price Target: $155 → $175
Current: $105.85
Upside: +65.33%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $189.92
Upside: +39.53%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $4.86
Upside: +373.25%
Dec 11, 2024
Upgrades: Buy
Price Target: $44 → $50
Current: $26.56
Upside: +88.25%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $10.50
Upside: +90.48%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $43.67
Upside: +71.74%
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $450
Current: $244.98
Upside: +83.69%
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $450
Current: $225.29
Upside: +99.74%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $103.12
Upside: +60.01%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $44.85
Upside: +0.33%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $22.64
Upside: +23.67%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $95.54
Upside: +51.77%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $41.53
Upside: +48.81%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $323.44
Upside: -7.25%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $2.93
Upside: +207.17%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $3.30
Upside: -16.67%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $226.02
Upside: +15.03%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $3.26
Upside: +84.05%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $8.01
Upside: +299.50%